Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion By: MarketWatch October 08, 2023 at 19:34 PM EDT Mirati develops commercial-stage oncology therapies, and through the deal, Bristol Myers Squibb will add lung-cancer medicine Krazati, among others, to its portfolio. Read More >> Related Stocks: Bristol-Myers Squibb Mirati Therapeutics Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion By: MarketWatch October 08, 2023 at 19:34 PM EDT Mirati develops commercial-stage oncology therapies, and through the deal, Bristol Myers Squibb will add lung-cancer medicine Krazati, among others, to its portfolio. Read More >> Related Stocks: Bristol-Myers Squibb Mirati Therapeutics